Ortho RTi receives extension on 2.1M+ warrants: 3 observations

Written by Mackenzie Garrity | August 01, 2018 | Print  |

Ortho Regenerative Technologies earned extensions of expiry dates on certain warrants.

Here are three observations:

1. The warrants were issued with private placements that closed prior to Ortho RTi's shares being listed.

2. An aggregate of 2.11 million warrants earned extensions. They were originally scheduled to expire throughout 2018 and 2019.

3. The extension is for an added year from their respective maturity dates. All other terms of the extended warrants remain unchanged.

More articles on biologics:
3 things to know about Tom Cycyota, AlloSource president & CEO
5 things to know about BioRestorative Therapies
1st patient enrolled in Cerapedics' TLIF clinical trial: 5 takeaways

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months